Cell proliferation in Helicobacter pylori associated gastritis and the effect of eradication therapy

Gut

Volumn 36, Issue 3, 1995, Pages 346-350

  Lynch, D A F ^a   Mapstone, N P ^a,b   Clarke, A M T ^b   Sobala, G M ^a   Jackson, P ^b   Morrison, L ^b   Dixon, M F ^a,b   Quirke, P ^a,b   Axon, A T R ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Cell proliferation; Gastric cancer; Helicobacter pylori; Type B gastritis

Indexed keywords

BISMUTH CITRATE; METRONIDAZOLE; TETRACYCLINE;

ADULT; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; GASTRITIS; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; STOMACH CANCER; STOMACH ULCER;

EID: 0028966676     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.36.3.346     Document Type: Article

References (28)

1. Morson BC. Intestinal metaplasia of the gastric mucosa. Br J Cancer 1955; 9: 365.
2. Correa P. The gastric precancerous process. Cancer Surv 1983; 2: 437-50.
3. Nomura A, Stemmermann GN, Chyou P, Kato I, PerezPerez GI, Blaser MJ. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991; 325 (16): 1132-6.
4. Forman D, Newell DG, Fullerton F, Yarnell JWG, Stacey AR, Wald N, et al. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. BMJ 1991; 302: 1302-5.
5. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325: 1127-31.
6. The Eurogast Study Group. An international association between Helicobacter pylori infection and gastric cancer. Lancet 1993; 341: 1359-62.
7. Medline A, Farber E. The multi-step theory of neoplasia. In: Anthony PP, Sweeney RNM, eds. Recent advances in histopathology. No 11. Edinburgh: Churchill Livingstone, 1981: 19-34.
8. Freling RI. Culture of animal cells. A manual of basic technique. 2nd ed. New York: Alan R Liss Inc, 241-4.
9. Lynch DAF, Clarke AMT, Jackson P, Axon ATR, Dixon MF, Quirke P. Comparison of labelling by bromodeoxyuridine, MIB-1 and proliferating cell nuclear antigen in gastric mucosal biopsies. J Clin Pathol 1994; 47: 122-5.
10. Lacy ER, Kuwayama H, Cowart KS, King JS, Deutz AH, Sistrunk S. A rapid, accurate immunohistochemical method to label proliferating cells in the digestive tract. A comparison with tritiated thymidine. Gastroenterology 1991; 100: 259-62.
11. Ohyama S, Yonemura Y, Miyazaki I. Proliferative activity and malignancy in human gastric cancers: significance of the proliferation rate and its clinical application. Cancer 1992; 69: 314-21.
12. Hall PA, Hart I, Goodlad R, Coates PJ, Lane DP. Expression of proliferating cell nuclear antigen in noncycling cells. J Pathol 1992; 168: 97A.
13. Wisman JH, Van Dierendonck JH, Keijzer R, Van de Velde CJH, Cornelisse CJ. Immunoreactivity of proliferating cell nuclear antigen compared with bromodeoxyuridine incorporation in normal and neoplastic rat tissue. J Pathol 1992; 168: 75-83.
14. Emery P, Salmon M. Systemic mediators of inflammation. Br J Hosp Med 1991; 45: 164-8.
15. Lunec J. Free radicals: their involvement in disease processes. Ann Clin Biochem 1990; 27: 173-82.
16. Jankowski J, Al-Rawi HJ, Johnston DA, Hopwood D, Filipe MI, Coghill G, et al. Growth regulatory peptides in gastric mucosa. Clin Sci 1992; 82: 581-7.
17. Hansen OH, Johansen AA, Larsen JK, Svendson LB. Cell proliferation in normal and diseased gastric mucosa. Acta Pathologies, et Microbiologica Scandinavica 1979; 87: 217-22.
18. Yong-ling X, Zhi-tian Z. Cell proliferation kinetics in chronic gastritis and gastric cancer. Chin Med J (Engl) 1984; 97: 526-32.
19. Dixon MF. Helicobacter pylori and peptic ulceration: Histopathological aspects. Journal of Gastroenterology & Hepatology 1991; 6: 125-30.
20. Axon ATR, Lynch DAF. Helicobacter pylori, gastric physiology and cancer. European Journal of Gastroenterology & Hepatology 1993; 5 (suppl 1): S100-13.
21. Ames BN, Gold LS. Too many rodent carcinogens: mitogenesis increases mutagenesis. Science 1990; 249: 970-1.
22. Mirvish SS, Wallcave L, Eagen M, Shubik P. Ascorbatenitrite reaction: possible means of blocking the formation of carcinogenic N-nitrosocompounds. Science 1992; 177: 65-8.
23. Mackerness CW, Leach SA, Thompson MH, Hill MJ. The inhibition of bacterially mediated-nitrosation by vitamin C: relevance to the inhibition of endogenous N-nitrosation in the achlorhydric stomach. Carcinogenesis 1989; 10: 397-9.
24. Sobala GM, Schorah CJ, Sanderson M, Dixon MF, Tompkins DS, Godwin P, et al. Ascorbic acid in the human stomach. Gastroenterology 1989; 97: 357-63.
25. Rathbone BJ, Johnson AW, Wyatt JI, Kelleher J, Heatley RV, Losowsky MS. Ascorbic acid: a factor concentrated in human gastric juice. Clin Sci 1989; 76: 237-41.
26. Sobala GM, Schorah CJ, Shires S, Lynch DAF, Gallacher B, Dixon MF, et al. Effect of eradication of Helicobacter pylori on gastric juice ascorbic acid concentrations. Gut 1993; 34: 1038-41.
27. Lanza FL, Skoglund ML, Rack MF, Yardley JH. The effect of bismuth subsalicylate on the histologic gastritis seen with Campylobacter pylori: a placebo-controlled, randomized study. Am J Gastroenterol 1991; 86 (1): 16-25.
28. Rauws EAJ, Langenburg W, Houthoff HJ, Zanen HC, Tytgat GNJ. Campylobacter pyloridis associated chronic antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology 1988; 94: 33-40.